138 related articles for article (PubMed ID: 6247604)
1. Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.
De Marinis L; Barbarino A
Metabolism; 1980 Jul; 29(7):599-604. PubMed ID: 6247604
[TBL] [Abstract][Full Text] [Related]
2. Insulin and growth hormone regulation in organic hyperinsulinism.
AvRuskin TW; Coran AG; Crigler JF
Surg Gynecol Obstet; 1971 Jul; 133(1):1-10. PubMed ID: 4326382
[No Abstract] [Full Text] [Related]
3. Calcium antagonists and hormone release. VIII. Effects of verapamil infusion on C-peptide to insulin molar ratio in normal subjects and obese subjects with normal glucose tolerance.
De Marinis L; Mancini A; Zuppi P; Sammartano L; Valle D; Fiumara C; Sandric S; Folli G
Diabetes Res; 1992 Jan; 19(1):9-16. PubMed ID: 1468187
[TBL] [Abstract][Full Text] [Related]
4. Qualitative abnormality of insulin secretion in a case with insulinoma.
Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M
Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060
[TBL] [Abstract][Full Text] [Related]
5. [Effects of calcium antagonists on pancreatic endocrine secretion].
Vincenzi V; Fioroni E; Benvegnù B; De Angelis M; Bartolucci L; Gradoli C; Valori C
Minerva Med; 1985 May; 76(19-20):919-21. PubMed ID: 3889722
[TBL] [Abstract][Full Text] [Related]
6. Effect of verapamil on glucose response to intravenous injection of glucagon and insulin in healthy subjects.
Röjdmark S; Andersson DE; Hed R; Sundblad L
Horm Metab Res; 1980 Jul; 12(7):285-90. PubMed ID: 6995247
[TBL] [Abstract][Full Text] [Related]
7. Calcium antagonists and hormone release. VII. Effects of gallopamil infusion on insulin and C peptide release in normal subjects.
De Marinis L; Mancini A; Fiumara C; Camaioni M; Zuppi P; Conte G; Folli G
Diabetes Res; 1991 Jun; 17(2):93-7. PubMed ID: 1817816
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil.
Devis G; Somers G; Van Obberghen E; Malaisse WJ
Diabetes; 1975 Jun; 24(6):247-51. PubMed ID: 1095438
[TBL] [Abstract][Full Text] [Related]
9. Calcium antagonists and hormone release. VI. Effects of a calcium antagonist (verapamil) on the biphasic insulin release in vivo.
Barbarino A; De Marinis L; Mancini A; Calabrò F; Massari M; D'Amico C; Sambo P; Tofani A; Folli G
Diabetes Res; 1988 May; 8(1):21-4. PubMed ID: 3066562
[TBL] [Abstract][Full Text] [Related]
10. Insulin and proinsulin release during calcium infusion in a patient with islet-cell tumor.
Gaeke RF; Kaplan EL; Rubenstein A; Starr J; Burke G
Metabolism; 1975 Sep; 24(9):1029-34. PubMed ID: 168454
[TBL] [Abstract][Full Text] [Related]
11. Insulin and somatostatin releasing islet cell tumor caused hypoglycemia.
Karasawa Y; Mochizuki T; Kawa S; Aoki Y; Ueno T; Watanabe T; Kawasaki S; Miyagawa S; Itoh N; Tamai C; Sakurai A; Kiyosawa K
Intern Med; 2001 Apr; 40(4):324-30. PubMed ID: 11334393
[TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists and hormone release. IV. The role of calcium in glucose-stimulated early phase insulin release in vivo.
De Marinis L; Merlini G; Makhoul O; Barbarino A
J Endocrinol Invest; 1982; 5(2):121-4. PubMed ID: 7047633
[TBL] [Abstract][Full Text] [Related]
13. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
Hofeldt FD; Dippe SE; Levin SR; Karam JH; Blum MR; Forsham PH
Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
[No Abstract] [Full Text] [Related]
14. Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin.
Hirsch HJ; Loo S; Evans N; Crigler JF; Filler RM; Gabbay KH
N Engl J Med; 1977 Jun; 296(23):1323-6. PubMed ID: 193007
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral verapamil on glibenclamide stimulated insulin secretion.
Semple CG; Omile C; Buchanan KD; Beastall GH; Paterson KR
Br J Clin Pharmacol; 1986 Aug; 22(2):187-90. PubMed ID: 3092851
[TBL] [Abstract][Full Text] [Related]
16. Modulation by verapamil of insulin and glucagon secretion in man.
Giugliano D; Gentile S; Verza M; Passariello N; Giannetti G; Varricchio M
Acta Diabetol Lat; 1981; 18(2):163-71. PubMed ID: 7018149
[TBL] [Abstract][Full Text] [Related]
17. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
18. Defective regulation of insulin release and transmembrane Ca2+ fluxes by human islet cell tumours.
Flatt PR; Swanston-Flatt SK; Powell CJ; Marks V
Br J Cancer; 1987 Oct; 56(4):459-64. PubMed ID: 2825749
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcium antagonist on glucose-induced insulin and glucagon secretion in rats with insulin-secreting tumors induced by streptozotocin and nicotinamide.
Baba S; Yoshino G; Kazumi T; Fujii S; Yoshida Y; Taniguchi H; Morita S
Kobe J Med Sci; 1979 Jun; 25(2):93-104. PubMed ID: 224248
[No Abstract] [Full Text] [Related]
20. Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil.
Fadda GZ; Akmal M; Soliman AR; Lipson LG; Massry SG
Kidney Int; 1989 Nov; 36(5):773-9. PubMed ID: 2559234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
